Novel Method for Mass Production of Recombinant Proteins Using MSG
On 30th May, 2024, researchers at the Indian Institute of Science (IISc) unveiled a novel method to mass produce recombinant proteins, including vaccine antigens and insulin, replacing hazardous methanol with mono-sodium glutamate (MSG).
- The new expression system aims to produce proteins for biotech industries, including milk and egg proteins, baby food supplements, nutraceuticals, and therapeutic molecules.
- An Indian patent has been granted, and a US patent has been filed for the novel expression system, with plans to collaborate with industry partners for scaling up production.
- The conventional method involves using methanol to activate yeast cells, which poses significant safety risks due to its ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Brain-Computer Interface to Restore Natural Speech
- 2 Neuralink to Implant 'Blindsight' Chip in First Human by 2025
- 3 Unexpected Atmospheric Gas on Exoplanet K2-18b
- 4 India Signs Deal with France for 26 Rafale-Marine Fighter Jets
- 5 SpaceX Launches Historic Fram2 Mission
- 6 Indian Army Inducts Indigenous FPV Drones
- 7 India’s First Prototype Fast Breeder Reactor Set for Commissioning in 2025
- 8 Google Launches Ironwood: 7th-Generation TPU for AI Workloads
- 9 QpiAI-Indus Quantum Computer
- 10 Blood Test for Cervical Cancer Monitoring